CGH
ASTH icon

Crossmark Global Holdings’s Astrana Health ASTH Stock Holding History

Crossmark Global Holdings’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,410
Closed -$251K – 1395
2021
Q4 		$251K Buy
+3,410
New +$280K 0.01% 1241

Other funds holding ASTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Crossmark Global Holdings's ASTH Position: Q1 2022 in Review

Crossmark Global Holdings sold out of Astrana Health (ASTH) in Q1 2022, closing a stake of 3,410 shares — an estimated $251K sold.

Crossmark Global Holdings first reported a position in ASTH in Q4 2021 and held it in 1 quarter. The position peaked at $251K in Q4 2021. 139 funds tracked by Wall St. Rank hold ASTH as of Q1 2022.

  • Crossmark Global Holdings reported no remaining Astrana Health position as of Q1 2022 after selling out during the quarter.
  • Crossmark Global Holdings sold 3,410 Astrana Health shares in Q1 2022, an estimated $251K.
  • Crossmark Global Holdings first reported a position in Astrana Health in Q4 2021 and held it in 1 quarter.
  • Crossmark Global Holdings's Astrana Health position peaked at $251K in Q4 2021.
  • 139 funds tracked by Wall St. Rank held Astrana Health as of Q1 2022.

Based on Crossmark Global Holdings's 13F filing for Q1 2022, filed 11 May 2022.